112 related articles for article (PubMed ID: 11050005)
1. A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells.
Mochizuki N; Shimizu S; Nagasawa T; Tanaka H; Taniwaki M; Yokota J; Morishita K
Blood; 2000 Nov; 96(9):3209-14. PubMed ID: 11050005
[TBL] [Abstract][Full Text] [Related]
2. Role of the RUNX1-EVI1 fusion gene in leukemogenesis.
Maki K; Yamagata T; Mitani K
Cancer Sci; 2008 Oct; 99(10):1878-83. PubMed ID: 19016745
[TBL] [Abstract][Full Text] [Related]
3. RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein alpha function.
Tokita K; Maki K; Mitani K
Cancer Sci; 2007 Nov; 98(11):1752-7. PubMed ID: 17894555
[TBL] [Abstract][Full Text] [Related]
4. Targeting a DNA binding motif of the EVI1 protein by a pyrrole-imidazole polyamide.
Zhang Y; Sicot G; Cui X; Vogel M; Wuertzer CA; Lezon-Geyda K; Wheeler J; Harki DA; Muzikar KA; Stolper DA; Dervan PB; Perkins AS
Biochemistry; 2011 Dec; 50(48):10431-41. PubMed ID: 22039883
[TBL] [Abstract][Full Text] [Related]
5. [EVI1 expression, clinical and cytogenetical characteristics in 447 patients with acute myeloid leukemia].
He XF; Wang QR; Cen JN; Qiu HY; Sun AN; Chen SN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Nov; 37(11):936-941. PubMed ID: 27995876
[TBL] [Abstract][Full Text] [Related]
6. Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR.
Boyd KE; Xiao YY; Fan K; Poholek A; Copeland NG; Jenkins NA; Perkins AS
Blood; 2006 Jan; 107(2):733-41. PubMed ID: 16204320
[TBL] [Abstract][Full Text] [Related]
7. Oncogene
Pastoors D; Havermans M; Mulet-Lazaro R; Brian D; Noort W; Grasel J; Hoogenboezem R; Smeenk L; Demmers JAA; Milsom MD; Enver T; Groen RWJ; Bindels E; Delwel R
Sci Adv; 2024 May; 10(20):eadk9076. PubMed ID: 38748792
[TBL] [Abstract][Full Text] [Related]
8. Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.
Marchesini M; Gherli A; Simoncini E; Tor LMD; Montanaro A; Thongon N; Vento F; Liverani C; Cerretani E; D'Antuono A; Pagliaro L; Zamponi R; Spadazzi C; Follini E; Cambò B; Giaimo M; Falco A; Sammarelli G; Todaro G; Bonomini S; Adami V; Piazza S; Corbo C; Lorusso B; Mezzasoma F; Lagrasta CAM; Martelli MP; La Starza R; Cuneo A; Aversa F; Mecucci C; Quaini F; Colla S; Roti G
Nat Commun; 2024 Jun; 15(1):4739. PubMed ID: 38834613
[TBL] [Abstract][Full Text] [Related]
9. Promoter-centred chromatin interactions associated with EVI1 expression in EVI1+3q- myeloid leukaemia cells.
Ng HL; Robinson ME; May PC; Innes AJ; Hiemeyer C; Feldhahn N
Br J Haematol; 2024 Mar; 204(3):945-958. PubMed ID: 38296260
[TBL] [Abstract][Full Text] [Related]
10. A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes.
Vandepoele K; Andries V; Van Roy N; Staes K; Vandesompele J; Laureys G; De Smet E; Berx G; Speleman F; van Roy F
PLoS One; 2008 May; 3(5):e2207. PubMed ID: 18493581
[TBL] [Abstract][Full Text] [Related]
11. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation.
Nishikata I; Sasaki H; Iga M; Tateno Y; Imayoshi S; Asou N; Nakamura T; Morishita K
Blood; 2003 Nov; 102(9):3323-32. PubMed ID: 12816872
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional control of brown fat determination by PRDM16.
Seale P; Kajimura S; Yang W; Chin S; Rohas LM; Uldry M; Tavernier G; Langin D; Spiegelman BM
Cell Metab; 2007 Jul; 6(1):38-54. PubMed ID: 17618855
[TBL] [Abstract][Full Text] [Related]
13. Cardiac-specific inactivation of
Nam JM; Lim JE; Ha TW; Oh B; Kang JO
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H764-H777. PubMed ID: 32083975
[TBL] [Abstract][Full Text] [Related]
14. PRDM16 functions as a suppressor of lung adenocarcinoma metastasis.
Fei LR; Huang WJ; Wang Y; Lei L; Li ZH; Zheng YW; Wang Z; Yang MQ; Liu CC; Xu HT
J Exp Clin Cancer Res; 2019 Jan; 38(1):35. PubMed ID: 30683132
[TBL] [Abstract][Full Text] [Related]
15. The Multifaceted Roles of PRDM16: Adipose Biology and Beyond.
Chi J; Cohen P
Trends Endocrinol Metab; 2016 Jan; 27(1):11-23. PubMed ID: 26688472
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukemia with rare recurring translocations-an overview of the entities included in the international consensus classification.
Rørvik SD; Torkildsen S; Bruserud Ø; Tvedt THA
Ann Hematol; 2024 Apr; 103(4):1103-1119. PubMed ID: 38443661
[TBL] [Abstract][Full Text] [Related]
17. The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis.
Bathina S; Armamento-Villareal R
Front Endocrinol (Lausanne); 2023; 14():1168687. PubMed ID: 37576965
[TBL] [Abstract][Full Text] [Related]
18. PRDM16 deficiency in vascular smooth muscle cells aggravates abdominal aortic aneurysm.
Wang Z; Zhao X; Zhao G; Guo Y; Lu H; Mu W; Zhong J; Garcia-Barrio M; Zhang J; Chen YE; Chang L
JCI Insight; 2023 Jun; 8(11):. PubMed ID: 37079380
[TBL] [Abstract][Full Text] [Related]
19. PRDM16 Regulating Adipocyte Transformation and Thermogenesis: A Promising Therapeutic Target for Obesity and Diabetes.
Jiang N; Yang M; Han Y; Zhao H; Sun L
Front Pharmacol; 2022; 13():870250. PubMed ID: 35462933
[TBL] [Abstract][Full Text] [Related]
20. MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma.
Li M; Ren H; Zhang Y; Liu N; Fan M; Wang K; Yang T; Chen M; Shi P
Front Oncol; 2022; 12():772686. PubMed ID: 35174083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
